Results 11 to 20 of about 938,592 (268)

Performance of a novel DiaRD-HCV RNA RTqPCR kit for quantification of HCV RNA in clinical samples [PDF]

open access: yesEuropean Journal of Clinical Microbiology & Infectious Diseases
Abstract Purpose Quantitative detection of hepatitis C virus (HCV) RNA is essential for diagnosis of chronic infection and monitoring the HCV levels in patients under treatment. In this study, we aimed to evaluate the performance characteristics and comparability of a novel DiaRD-HCV RT qPCR kit (Diagen Lts, Ankara ...
Ulker Cuhaci   +6 more
openaire   +3 more sources

Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients [PDF]

open access: yesViruses, 2021
Background: The impact of Hepatitis C virus (HCV) RNA levels on the evolution of chronic HCV infection-related liver damage is controversial. Heavy alcohol use is believed to have a deleterious impact on the course of HCV disease, but current knowledge ...
Daniel Fuster   +4 more
doaj   +2 more sources

Early Changes in Hepatitis C Virus (HCV) RNA Levels Predict Response to Interferon Treatment in Non-Cirrhotic HCV Patients [PDF]

open access: yesCanadian Journal of Gastroenterology, 2000
The role of hepatitis C virus (HCV) RNA quantification in determining ideal interferon (IFN) treatment of noncirrhotic HCV liver disease is uncertain. The specific aim of this study was to determine whether measurement of baseline HCV RNA or changes in ...
Glen Fallows   +6 more
doaj   +2 more sources

Clinical Performance of the Elecsys HCV Duo Immunoassay Compared with a Standard-of-Care Algorithm Using Alinity Anti-HCV Screening and HCV RNA Confirmation [PDF]

open access: yesDiagnostics
Background/Objectives: The Elecsys HCV Duo immunoassay simultaneously detects HCV core antigen (HCV Ag) and anti-HCV antibodies in a single sample. We evaluated its clinical performance against a standard-of-care reference algorithm of anti-HCV antibody ...
Jaeeun Yoo   +8 more
doaj   +2 more sources

HCV RNA quantification using the Cobas Plasma Separation Card as an alternative to EDTA plasma: a prospective multicenter study [PDF]

open access: yesScientific Reports
Simplified diagnostic approaches are needed to eliminate hepatitis C by 2030. This prospective multicenter study evaluated dried plasma spots collected with the Cobas® Plasma Separation Card (PSC) versus conventional ethylenediaminetetraacetic acid (EDTA)
Ana Fuentes López   +16 more
doaj   +2 more sources

Independent assessment of a point of care HCV RNA test by laboratory analytical testing and a prospective field study in the U.S. [PDF]

open access: yesPLoS ONE
Improvements in HCV testing, including Point of Care (POC) HCV RNA tests, are necessary to eliminate HCV. With this goal in mind, we established methods to collect capillary whole blood (CWB) via fingerstick, ensured its stability in a microtainer, and ...
Lesley S Miller   +15 more
doaj   +2 more sources

Comparison of Assays for HCV RNA

open access: yesLancet, The, 1993
M de Medina
exaly   +2 more sources

Improving Diagnosis of Hepatitis C Virus Infection Using Hepatitis C Core Antigen Testing in a Resource-Poor Setting

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2021
INTRODUCTION: We compared the hepatitis C virus (HCV) core antigen test with the HCV RNA assay to confirm anti-HCV results to determine whether the HCV core antigen test could be used as an alternative confirmatory test to the HCV RNA test.
Ayswarya Kannan   +7 more
doaj   +1 more source

HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs [PDF]

open access: yesPeerJ, 2017
The core antigen of the hepatitis C virus (HCV Ag) presents an alternative marker to HCV RNA when screening patients for HCV viremia. This study sought to evaluate the utility of HCV Ag as a marker to assess active HCV infection in individuals residing ...
Rujipat Wasitthankasem   +7 more
doaj   +2 more sources

Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland [PDF]

open access: yes, 2012
Prevalence of the hepatitis C virus (HCV) among people who inject drugs (PWID) in Scotland is high. The Scottish Government has invested significantly in harm reduction interventions with the goal of reducing HCV transmission among PWID.
Hutchinson, Sharon   +5 more
core   +4 more sources

Home - About - Disclaimer - Privacy